China Merchants Life Science's first increase in holding shares of Renfu Medicine, costing 12.4253 million yuan.

On the evening of April 30th, Renfu Medicine announced that on April 30th, CMB Life Sciences increased its stake in the company by 594,500 shares through centralized bidding, accounting for approximately 0.04% of the total share capital of the company. The total amount of the increase was 12.4253 million yuan, with an average price of 20.9 yuan per share. The increase plan has not yet been completed, and CMB Life Sciences will continue to increase its stake in the company at an appropriate time. This is the first increase in Renfu Medicine announced by CMB Life Sciences after the plan to increase its stake was announced, with only 1 day between the announcement on April 28th and the first increase.